Q&A with CNS Expert, Dr. Michael Liebowitz

January 8, 2019

Dr. Michael Liebowitz, a member of WCG’s Scientific Leadership Team, shared his insights during a recent conversation with Mark Opler, PhD, MPH, chief research officer at WCG’s MedAvante-ProPhase. Dr. Liebowitz, a pioneer in social anxiety disorders, is a Columbia University psychiatrist and founder of the Anxiety Disorders Clinic, the first of its kind, at the New York State Psychiatric Institute. He also developed the Liebowitz Social Anxiety Scale (LSAS).

Previous Flipbook
Increased Signal Detection in Alzheimer's Disease Clinical Trials
Increased Signal Detection in Alzheimer's Disease Clinical Trials

This study investigated the impact of lag time on error rates for commonly used Alzheimer’s disease COAs, a...

Next Flipbook
Genetic Counselors at the Forefront of Helping Researchers Brace for the "Silver Tsunami" of CNS Disorders
Genetic Counselors at the Forefront of Helping Researchers Brace for the "Silver Tsunami" of CNS Disorders

An aging population is triggering a “silver tsunami” of neurodegenerative diseases like Alzheimer’s and Par...